Hemp-Derived Products Like Delta-8 THC Are ‘Here To Stay,’ Says Analyst

As the cannabis and hemp industries continue to expand, the regulation of hemp-derived products, such as Delta-8 THC, has become a focal point of debate. Pablo Zuanic, a highly-respected equity analyst following the cannabis and psychedelics industries and an upcoming speaker at the Benzinga Cannabis Capital conference, addressed the future of hemp derivatives during a recent interview.

With evolving state regulations and increasing market share, Zuanic said that these products are becoming a permanent part of the industry.

Hemp’s Growing Role in the Market

Hemp-derived products have rapidly gained popularity, leading to a highly fragmented market with various players across the supply chain. Zuanic explained the widespread presence of hemp derivatives in the U.S. market. “Hemp derivatives are here to stay,” he said. He described the hemp industry as “a very democratic industry, a very competitive capitalist industry” due to its diverse components, including farmers, processors, and manufacturers.

Although hemp-derived products like Delta-8 …

Full story available on Benzinga.com